EPCAM and Patent ductus arteriosus: By using a such system, which captures tumor cells from whole blood based on EpCAM and cytokeratin expression, a PDA diagnosis was made in 32 % of patients in a cohort consisting of advanced PDA and 7 % in a cohort consisting of early stage PDA [41, 42].